您的位置：首页 > 新闻中心 > 社会 > 正文

可凡倾听

New York is shaking up its legal marijuana market with new competitors_我的网站

神雕侠侣

A | “离开皇马，你的身价会只剩1/4。” 当穆里尼奥在电话中对维尼修斯说出这句话时，持续18个月的续约拉锯战瞬间画上句号。外界看到了师徒情深，看到了名帅指点迷津。然而，在伯纳乌的权力辞典里，这句话并非忠告，而是一份冰冷判决书——穆里尼奥作为弗洛伦蒂诺的“执剑人”，用21个字，让维尼修斯彻底放弃了“争一哥”的幻想，签字画押，接受了皇马体系里“二号人物”的位置。 RAVENA, N.Y. -- New York officials launched legal recreational marijuana sales by promising many of the first retail licenses to people with past drug convictions, hoping to give people harmed by the war on drugs a chance to succeed before competitors crowded in.But more than nine months after sales started, only about two dozen state-sanctioned dispensaries have opened their doors. Legal challenges over the state's permitting process have left more than 400 provisional licensees in limbo. Marijuana farmers are reeling because there are too few stores to sell their harvest.State regulators are now expanding the market amid those troubles. They recently opened up a 60-day general application window to grow, process, distribute or sell marijuana, expecting to issue more than 1,000 new licenses. New rules also will allow companies licensed to grow and sell medical marijuana in New York to get into the recreational market.The moves are expected to boost the number of legal dispensaries in a market now dominated by black-market sellers who simply opened retail stores without a license. But the prospect of competing with the medical providers worries some farmers and retailers who fear being squeezed by deeper-pocketed companies before they had a chance to establish themselves.“My concern is that they have all the money to bleed us out,” said Coss Marte, whose opening of CONBUD dispensary in Manhattan was pushed back by a lawsuit against state regulators. “They’re vertically integrated. So now what they could do is ... grow their own product at the cheapest price and basically outbid all the farmers, all our products and all our pricing.”Critics blame New York’s slow retail growth partly on bureaucratic issues, like delays in setting up a $200 million “social equity” fund to help applicants open shops. The rollout also was hobbled by lawsuits on behalf of people and businesses excluded from the first wave of retail licenses. Marte's shop was among those temporarily blocked by a judge from opening after a group sued on behalf of disabled veterans, saying they were wrongly excluded from applying for a license. Marte, who has a past drug arrest, was paying rent on a store he could not open.A judge recently ruled that Marte's store and several others could open. But the fate of many other provisional license holders, like Carson Grant of New York City, was unclear. After months of delays in opening his store in Queens, he was debating whether to reapply for a license again in this general round.“It's very difficult emotionally,” he said.Reginald Fluellen, senior consultant with the Cannabis Social Equity Coalition, blamed the state for a botched rollout.“They’ve failed miserably in providing the justice-involved individuals the kind of head start, the kind of foothold, in the market that they promised," Fluellen said.Under new regulations, medical marijuana providers could begin retail recreational sales at one of their existing dispensaries as early as Dec. 29. They could begin selling recreational pot at two more dispensaries six months after that. The entry price for those companies is steep: a $20 million licensing fee, with $5 million due upfront. But multiple companies are expected to jump in.“We expect New York to be the hub, or one of the hubs, for legal cannabis on the East Coast,” said Curaleaf CEO Matt Darin. “And so we’re very bullish and we’ve invested a lot of capital and time to be able to maximize the opportunity.”Curaleaf, which operates in multiple states, has already invested $50 million in New York, most of it on a recently expanded indoor growing facility south of Albany that now serves the medical market. Rows of plants there mature in intensely lit rooms where humidity, temperature and nutrition are tightly controlled — a scene in stark contrast to the fields and greenhouses that have defined New York’s adult-use market since growing started last year.Curaleaf will be able to double the size of the facility’s canopy to 64,000 square feet, or about 1.5 acres (0.61 hectares), if the market dictates, said Joe Holland, an executive vice president.To guard against retail monopolies, the medical providers will be limited to three retail outlets. And in a nod to farmers, their shops will initially have to devote half their shelf space to products grown and processed by independent businesses.Still, critics say the state should have allowed more time for economically and socially diverse entrepreneurs to succeed before letting in larger competitors.Joseph Calderone of Grateful Valley Farm, near the Pennsylvania border, compared it to little hardware stores competing against big box stores. Large indoor facilities, he said, can produce multiple crops a year. Meanwhile, farms having trouble selling their crops are “teetering on the edge of failure,” he said.“We were given a fair chance to grow. We were asked to do that," he said. "We kept our promise. The state did not keep their promise.” Office of Cannabis Management executive director Chris Alexander said the new regulations maintain New York’s commitment to social and economic equity, while keeping the market more competitive than in other states. That includes giving priority consideration for social and equity applicants in the current round.While acknowledging there was some “frustration” in getting retail stores open, Alexander said the state has shown a market supplied by small farmers can work. "We've got some of the top-performing dispensaries in the country right here in New York," Alexander saidAnd there’s still room to grow. Regulators have estimated New York will eventually require at least 2,000 dispensaries to meet demand. “I think there’s enough business to go around,” said Christian Chavez, CEO of Statis Cannabis Co. He said sales have been good since they opened their dispensary in the Bronx in July. “I think it’ll be quite some time until this market gets saturated in New York.”。

B | 一、薪资博弈：一份被“打折”的核心合同续约的底层逻辑，永远是钱与权的博弈。维尼修斯团队的底牌非常明确：税后3000万欧元年薪 + 1500万欧元签字费，全面对标姆巴佩。场外的诱惑同样真实，阿森纳奉上了2500万至3000万欧元的年薪，并开出100%肖像权这一超级明星待遇。但皇马的态度异常强硬：2400万欧元，没有签字费。差距高达600万欧元年薪，维尼修斯为何低头？关键在于，穆里尼奥的话术精准击碎了一个幻觉。维尼修斯一直以为，自己是在和姆巴佩进行一场公平的“皇马一哥”争夺战。而现实是，当法国人免签落地的那一刻，他的核心地位就已被董事会、球迷和商业合同共同锁死。阿森纳的报价非但不是抬价筹码，反而成为一面镜子，照出了离开皇马的维尼修斯，即便拥有顶薪，也将永远失去伯纳乌的聚光灯与全球顶级的战术资源。所以，他在续约感谢信中特意提及穆里尼奥，不是尊重，是递上一份“投名状”：我明白了，我留下，并接受这个序列。

C | 二、数据铁证：谁才拥有“不防守”的终极特权？如果薪资排名是权力结构的表面文章，那球场上的防守数据，就是权力分配的底层代码。

D | 在The Athletic披露的权威数据面前，任何辩解都显得苍白。2025-26赛季，在西甲出场过的461名球员中，姆巴佩的“真实抢断尝试”次数排名倒数第一，场均仅约0.6次。他的压迫次数每90分钟仅有16.3次，而维尼修斯呢？高达33.3次，排在同位置第一梯队。更刺眼的是压迫效率。维尼修斯通过前场压迫夺回球权的次数，位列五大联赛所有前锋的前7%，而姆巴佩是垫底的3%。这组数据残酷地揭示了一个真相：在皇马的战术板里，那个可以站在前场等待“最后一击”的“特权核心”是姆巴佩。而维尼修斯，必须是那个深度回防、疯狂压迫、覆盖整条边路的“工兵型巨星”。他续约的代价，不仅是经济上的让步，更是体能上“一人干两人活”的承诺。三、战术服从：穆里尼奥的“六后卫”体系，容不下第二个散步者穆里尼奥在本菲卡打磨的“六后卫”反击体系，是其重夺欧冠的战术基石。这套打法要求边锋在防守时必须沉入肋部，形成极致密集的防线，反击时再瞬间弹开。这对体能和防守意愿的要求近乎变态。因此，问题从一开始就不是“维尼修斯和姆巴佩谁重要”，而是“谁能更好地为体系服务”。

E | 维尼修斯有着历史级别的纵向突破能力，同时具备满足穆帅要求的防守纪律性，他是这台精密机器上最合适的“驱动齿轮”。而姆巴佩，则是那个解决临门一脚的“终结者”。为了进一步巩固这个体系，皇马斥资1.4亿欧元签下迪奥曼德。

F | 这位19岁新星不仅能踢两边，防守参与度更高，而且比维尼修斯“更爱传球”。这步棋，是穆里尼奥对维尼修斯最精妙的“敲打”：你的武器库里必须加上无球跑动和积极分球，否则，位置并非不可替代。季前赛发布会上，穆帅那句“我没指望他今天就带球狂奔50米进球”，翻译成更衣室语言就是：你的才华，要用在团队防守和高效反击上，而不是个人表演。四、结局：一场没有悬念的权力重构连续两年四大皆空，更衣室内斗（楚阿梅尼与巴尔韦德冲突）公开化，弗洛伦蒂诺请回穆里尼奥，要的不是联赛——穆帅的联赛成绩历来不稳——而是欧冠淘汰赛上的铁血纪律与绝对服从。维尼修斯续约，是这场权力重构的最终落子。

G | 穆里尼奥用“身价暴跌论”诛心，用2400万的第二高薪安抚，用迪奥曼德的加盟制造危机。一套组合拳，收服了这位曾经觊觎王座的巴西天才。而站在权力金字塔顶端的，依然是姆巴佩那纹丝不动的3100万欧元年薪，和他那无人问责的防守数据。伯纳乌的权力游戏，从未有过公平竞争。有的只是，在狼群中认清自己的位置，并为了生存而战。七律·伯纳乌棋局狂人一语定乾坤，续约书成势已分。左路星芒双耀目，中军将令独尊君。